Analysis of ESR1 Mutation Spectrum from Non-Small-Cell Lung Cancer in Chinese Patients

被引：0
|
作者：
Xu, C. [1 ]
Wang, W. [2 ]
Zhang, Q. [3 ]
Zhuang, W. [4 ]
Zhu, Y. [5 ]
Huang, Y. [4 ]
Chen, Y. [3 ]
Chen, G. [3 ]
Fang, M. [2 ]
Lv, T. [6 ]
Song, Y. [6 ]
机构：
[1] Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China
[2] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
[3] Fujian Canc Hosp, Pathol, Fuzhou, Fujian, Peoples R China
[4] Fujian Canc Hosp, Med Oncol, Fuzhou, Fujian, Peoples R China
[5] Zhejiang Rongjun Hosp, Jiaxing, Peoples R China
[6] Jinling Hosp, Nanjing, Jiangsu, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
Non-small-cell lung cancer; Prognosis; ESR1; mutation;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.03-08
引用
收藏
页码：S913 / S913
页数：1
相关论文
共 50 条
  • [31] SURVIVAL ANALYSIS OF UNTREATED PATIENTS WITH NON-SMALL-CELL LUNG-CANCER
    VRDOLJAK, E
    MISE, K
    SAPUNAR, D
    ROZGA, A
    MARUSIC, M
    CHEST, 1994, 106 (06) : 1797 - 1800
  • [32] Exploration of lung mycobiome in the patients with non-small-cell lung cancer
    Yiming Zhao
    Junqi Yi
    Juanjuan Xiang
    Wei Jia
    Anqi Chen
    Liyu Chen
    Leliang Zheng
    Wen Zhou
    Minghua Wu
    Zheng Yu
    Jingqun Tang
    BMC Microbiology, 23
  • [33] Rare mutations in non-small-cell lung cancer
    D'Arcangelo, Manolo
    D'Incecco, Armida
    Cappuzzo, Federico
    FUTURE ONCOLOGY, 2013, 9 (05) : 699 - 711
  • [34] Clinicopathological characteristics of&IT POLE&IT mutation in patients with non-small-cell lung cancer
    Song, Zhengbo
    Cheng, Guoping
    Xu, Chunwei
    Wang, Wenxian
    Shao, Yang
    Zhang, Yiping
    LUNG CANCER, 2018, 118 : 57 - 61
  • [35] PIK3CA Mutations in Chinese Patients with Non-Small-Cell Lung Cancer
    Wu, B.
    Xu, C.
    Wang, W.
    Zheng, X.
    Zhuang, W.
    Song, Z.
    Lin, G.
    Chen, X.
    Chen, R.
    Guan, Y.
    Yi, X.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1940 - S1940
  • [36] Exploration of lung mycobiome in the patients with non-small-cell lung cancer
    Zhao, Yiming
    Yi, Junqi
    Xiang, Juanjuan
    Jia, Wei
    Chen, Anqi
    Chen, Liyu
    Zheng, Leliang
    Zhou, Wen
    Wu, Minghua
    Yu, Zheng
    Tang, Jingqun
    BMC MICROBIOLOGY, 2023, 23 (01)
  • [37] Impact of different patterns of metastasis in non-small-cell lung cancer patients
    da Silva, Larissy Machado
    da Silva, Gustavo Telles
    Bergmann, Anke
    Costa, Guilherme Jorge
    Zamboni, Mauro Musa
    Santos Thuler, Luiz Claudio
    FUTURE ONCOLOGY, 2021, 17 (07) : 775 - 782
  • [38] Intratumoral heterogeneity of KRAS mutation is rare in non-small-cell lung cancer
    Alsdorf, Winfried H.
    Clauditz, Till S.
    Hoenig, Tobias
    Quaas, Alexander
    Sirma, Hueseyin
    Koenig, Alexandra M.
    Izbicki, Jakob
    Sauter, Guido
    Marx, Andreas H.
    Grob, Tobias J.
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2013, 94 (01) : 155 - 159
  • [39] Application of proteomics in non-small-cell lung cancer
    Cho, William C. S.
    EXPERT REVIEW OF PROTEOMICS, 2016, 13 (01) : 1 - 4
  • [40] EGFR point mutation confers resistance to gefitinib in a patient with non-small-cell lung cancer
    Giaccone, G
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (06): : 296 - 297
12345